In today’s Pharma Pulse, the FDA expands a key biologic approval for pediatric patients, and new research highlights the success of pharmacist-led testing in rural communities.

For those managing pharmaceutical supply chains, the transition to low-carbon heat is no longer elective. Evolving regulatory frameworks, such as the European Union’s Carbon Border Adjustment ...

Ongoing conflict in the Middle East has pushed pharmaceutical companies into cold chain rerouting scrambles. Conflict in the Middle East is disrupting pharmaceutical supply chains, as the closure and ...

A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...

In today’s Pharma Pulse, Eli Lilly issues a safety warning and SteinCares enters a licensing agreement with Shilpa Biologicals to expand biosimilar access in Latin America. Welcome to Pharma Pulse, a ...

Kroger’s retail rollout shifts Zepbound KwikPen distribution from direct-to-consumer to community pharmacy channels, potentially reducing friction in initiation and refills for GLP-1 obesity therapy.

Orphan drugs are forecast to surpass $400 billion in 2032 sales, driven by accelerating rare disease innovation despite regulatory volatility, pricing pressures, and capital competition from ...

In a recent interview, Jay Bregman, founder and CEO of Andel, discussed his company's newly launched direct-to-employer medication platform, which is designed to reduce prescription drug costs by ...

Data provided by BackOps indicates significant performance gains for early adopters across various industries, including retail, grocery, and manufacturing. The platform reportedly accelerates ...